Z-0081-2021Class II
Biomet Regenerex Primary Taper Cap Item Number 141269
Zimmer GmbH / initiated 2020-09-04 / Terminated / root cause: sterility
Biomet, Inc. began a recall of Biomet Regenerex Primary Taper Cap Item Number 141269 on . FDA classified it as Class II and gives the reason as "Product not properly being aligned with the adequate gamma sterilization group and result in the product not being properly sterilized". As of , the recall status on record is Terminated, and MDM tags the root cause as sterility.
Recall record
- Recall number
- Z-0081-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Zimmer GmbH
- Product
- Biomet Regenerex Primary Taper Cap Item Number 141269
- Product code
- MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer
- Reason for recall
- Product not properly being aligned with the adequate gamma sterilization group and result in the product not being properly sterilized
- Root cause tag
- sterility
- FDA root cause
- Process change control
- Action
- Zimmer Biomet notified on 9/2/20 Distributors with direct sales and/or fielded inventory via email and traceable letter sent via FedEx. Hospitals with direct sales or current inventory, as well as hospitals that have consumed products in the past 12 months will be notified via FedEx. Surgeons that have consumed products with in the past 12 months notified via FedEx. Risk Manager Responsibilities: 1. Review this notification and ensure that affected personnel are aware of the contents. 2. If you have affected product at your facility, assist your Zimmer Biomet sales representative and quarantine all affected product. Your Zimmer Biomet sales representative will remove the affected product from your facility. 3. Complete Attachment 1 Certificate of Acknowledgement and send to [email protected]. This form will be returned even if you do not have affected products at your facility. 4. Retain a copy of the acknowledgement form with your recall records in the event of a compliance audit of your facilitys documentation. 5. If you have further questions or concerns after reviewing this notice, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday. Calls received outside of call center operating hours will receive a voicemail prompt or be transferred to an on-call representative in the event of an emergency. Alternatively, your questions may be emailed to [email protected]. Surgeon Responsibilities: 1. Review this notification for awareness of the contents. 2. There are no specific patient monitoring instructions related to this recall that are recommended beyond your existing follow-up schedule. 3. Complete Attachment 1 Certificate of Acknowledgement and send to [email protected]. 4. Retain a copy of the acknowledgement form with your recall records in the event of a compliance audit of your facilitys documentation. 5. If you ha
- Quantity in commerce
- US: 62 units; OUS: 176 units
- Distribution
- Nationwide Foreign: Canada, FINLAND, NETHERLANDS, UNITED KINGDOM
- Product codes and lots
- Lot Numbers: 015800 324440 685300 023900 324440R 696280 058930 389060 821980 200720 418430 890320 313260 646040 997610
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0081-2021 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0082-2021 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0083-2021 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-0084-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
